Skip to content
10-Q

Quarterly Report

Loxo Oncology, Inc.

0001104659-18-066990

← back to feed
Filed
Nov 8, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Oct 31, 2018 30.61M sh
Capex Q3 2018 · Sep 30, 2018 $3.73M
Capex Q3 2018 · Sep 30, 2017 $398K
Operating Cash Flow Q3 2018 · Sep 30, 2018 $13.42M
Operating Cash Flow restated Q3 2018 · Sep 30, 2017 −$113.12M
Short Term Investments Q3 2018 · Sep 30, 2018 $485.89M
Short Term Investments Q3 2018 · Dec 31, 2017 $484.18M
Cash And Equivalents Q3 2018 · Sep 30, 2018 $136.11M
Cash And Equivalents Q3 2018 · Dec 31, 2017 $142.03M
Cash And Equivalents Q3 2018 · Sep 30, 2017 $80.42M
Stockholders Equity Q3 2018 · Sep 30, 2018 $379.22M
Stockholders Equity Q3 2018 · Dec 31, 2017 $378.21M
Current Liabilities Q3 2018 · Sep 30, 2018 $173.77M
Current Liabilities Q3 2018 · Dec 31, 2017 $221.57M
Total Liabilities Q3 2018 · Sep 30, 2018 $280.01M
Total Liabilities Q3 2018 · Dec 31, 2017 $405.23M
Current Assets Q3 2018 · Sep 30, 2018 $628.31M
Current Assets Q3 2018 · Dec 31, 2017 $781.81M
Total Assets Q3 2018 · Sep 30, 2018 $659.23M
Total Assets Q3 2018 · Dec 31, 2017 $783.44M
Sga Expense Q3 2018 · Sep 30, 2018 $15.86M
Sga Expense Q3 2018 · Sep 30, 2018 $43.8M
Sga Expense Q3 2018 · Sep 30, 2017 $9.68M
Sga Expense Q3 2018 · Sep 30, 2017 $20.97M
Rd Expense Q3 2018 · Sep 30, 2018 $56.93M
Rd Expense Q3 2018 · Sep 30, 2018 $130.47M
Rd Expense Q3 2018 · Sep 30, 2017 $64.75M
Rd Expense Q3 2018 · Sep 30, 2017 $109.32M
Net Income Q3 2018 · Sep 30, 2018 −$27.06M
Net Income Q3 2018 · Sep 30, 2018 −$42.35M
Net Income Q3 2018 · Sep 30, 2017 −$73.32M
Net Income Q3 2018 · Sep 30, 2017 −$128.25M
Operating Income Q3 2018 · Sep 30, 2018 −$30.32M
Operating Income Q3 2018 · Sep 30, 2018 −$50.77M
Operating Income Q3 2018 · Sep 30, 2017 −$74.43M
Operating Income Q3 2018 · Sep 30, 2017 −$130.29M
Revenue Q3 2018 · Sep 30, 2018 $42.47M
Revenue Q3 2018 · Sep 30, 2018 $123.5M